Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Fast screening method of anti-bacilus tuberculosis medicine

A technology of mycobacterium tuberculosis and mycobacteria, which is applied in the field of medicine, can solve the problems of high cost and long screening time, and achieve the effect of low screening cost, short screening cycle and short detection cycle

Inactive Publication Date: 2011-09-07
THE KEY LAB OF CHEM FOR NATURAL PROD OF GUIZHOU PROVINCE & CHINESE ACADEMY OF SCI
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The technical problem to be solved by the present invention is to overcome the shortcomings of the existing screening methods such as long time, high cost, and possible false positives, and provide a rapid screening method for anti-mycobacterium tuberculosis drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Example 1: Rapid screening of compounds PW-1 (tetrandrine), PW-2 (tetrandrine), PW-3 (betulinic acid), PW-4 (β-amyresinol) and compound PW- 5 (Ruikuling) whether it has anti-mycobacterium tuberculosis activity.

[0021] The compound was dissolved in PHBS solution to prepare a 2 mg / mL PHBS solution, which was autoclaved for later use. The Mycobacterium tuberculosis H37Rv strain was formulated into 2 × 10 8 CFU / mL of bacterial suspension, add 100 μL of bacterial suspension, 100 μL of compound solution and 100 μL of serum to a 96-well plate, and the concentration of the compound solution is 666 μg / mL. After culturing in a 36°C incubator for 4 days, add 100 μL of 5 mmol / l Nitrocefin solution to each well, then place in a 36°C incubator for 30 minutes, and then measure the OD with a microplate reader 500 value. Isoniazid was used as a positive control, and the wells without any drug were used as negative controls.

[0022] Results: OD of negative control (i.e. no drug a...

Embodiment 2

[0023] Example 2. Screening compounds PW-1 (tetrandrine), PW-2 (tetrandrine), PW-3 (betulinic acid), PW-4 (β-amyresin) and Whether the compound PW-5 (Ruikuling) has anti-mycobacterium tuberculosis activity.

[0024] 1. Sample configuration: compound PW-1, PW-2, PW-3, PW-4, PW-5 and positive control drug (isoniazid) with 50% DMSO aqueous solution to make 10mg / mL mother solution, use Store in a refrigerator at 4°C after sterilizing with a bacterial filter.

[0025] 2. Anti-tuberculosis test

[0026] Prepare medium: measure 150mL distilled water and add 0.7g KH 2 PO 4 , 0.06g MgSO4 , 0.15g magnesium citrate, 0.9g asparagine, 2.0g monosodium glutamate, heat to dissolve at 80°C, and add 7.5g potato flour when cooling to 60°C. Add 250mL of whole egg liquid and 5mL of 2% malachite green aqueous solution, and mix well. Add 3 mL of glycerin, 1.0 mL of Tween-80, 1.0 mL of 0.1% PHA, 10 mL of calf serum, 0.5 mL of 1% zinc sulfate, and 1 mL of niacin solution of 200 μg / mL after filter...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a fast screening method of an anti-bacilus tuberculosis medicine. The method comprises the following steps: adding a PHBS solution containing a medicine to be screened and serum into a bacilus tuberculosis suspension; incubating the mixture in an incubator at 20-36 DEG C for 3-5 days, then adding a Nitrocefin solution and continuing the incubation for 20-40 minutes; and measuring the OD500 value, wherein when the OD500 value is less than 0.64, the medicine to be screened is the anti-bacilus tuberculosis medicine. The method is substantially based on an in-vitro screening model of bacilus tuberculosis cellular level with the best representativeness, and the detection result has strong representativeness; the method can test through an elisa plate, has the advantages of small sample dosage, short detection period and relatively sensitive detection result, and can realize high-flux screening; the screening period is short, the incubation time of the bacilus tuberculosis is shortened to about 4 days, and the screening cost is low; and meanwhile, the pollution is avoided, and the screening accuracy is high.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a rapid screening method for anti-tuberculosis mycobacterium drugs. Background technique [0002] Tuberculosis is an infectious disease infected with Mycobacterium tuberculosis, and it is one of the diseases with the longest history and the most serious consequences among the diseases that endanger human life and health. Half of the people who are in contact with Mycobacterium tuberculosis will be infected, and people who have been infected with Mycobacterium tuberculosis will have the risk of becoming a tuberculosis patient throughout their life, and 10% of people infected with Mycobacterium tuberculosis will develop the disease. Tuberculosis was once widespread all over the world. Since 1945, a variety of anti-tuberculosis chemical drugs came out, and the epidemic was once eased. However, due to stagnation in the development of anti-tuberculosis drugs and the increase in the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/18
Inventor 潘卫东杨再昌梁光义李天磊景书灏
Owner THE KEY LAB OF CHEM FOR NATURAL PROD OF GUIZHOU PROVINCE & CHINESE ACADEMY OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com